XBiotech Pauses Rheumatology program
December 23, 2024 09:00 ET
|
XBiotech Inc.
AUSTIN, Texas, Dec. 23, 2024 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ: XBIT) announced today data that it is halting its clinical program in rheumatological disease while it seeks to understand the...
Breast Implants Market Growing at 9.6% CAGR, Reaching USD 6.16 Billion by 2032 | Introspective Market Research
December 20, 2024 07:36 ET
|
Introspective Market Research
United States, Dallas, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Breast implants are medical devices designed to enhance or reconstruct the breasts, offering women a versatile solution to achieve their...
Lifecore Biomedical to Report Financial Results for Second Quarter of Fiscal 2025 on January 2, 2025
December 19, 2024 16:05 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx™ Addressing Patients with Recurrent Pericarditis
December 19, 2024 08:30 ET
|
PRISM MarketView
PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx™
Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder Treatment
December 19, 2024 07:00 ET
|
Lifecore Biomedical, Inc.
Development Services Span Tech Transfer, Process Assessment and Method Validation for Fill and Finish of NRS-033 for Planned Phase 2 Trial Lifecore to Leverage Differentiated Capabilities and...
Clinical Trial Outsourcing Market Expected To Reach USD 111.01 Billion by 2032, Growing at a CAGR of 8.7% From 2024-2032 | Introspective Market Research
December 19, 2024 06:27 ET
|
Introspective Market Research
United Kingdom, London, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Australian healthcare technology company Resonance Health completed the acquisition of 100% of clinical research center TrialsWest for a...
YPrime Commits to United Nations Global Compact, Pledging to Align its Sustainable Business Practices with UN Goals
December 17, 2024 09:57 ET
|
Y-Prime, LLC
YPrime pledges to United Nations Global Compact, expanding its program of sustainable business practices.
Anti-Aging Market Expected to Reach USD 2.29 Billion by 2032, Growing at a CAGR of 7.6% From 2024-2032 | Introspective Market Research
December 12, 2024 10:34 ET
|
Introspective Market Research
United States, New York, Dec. 12, 2024 (GLOBE NEWSWIRE) -- The Global Anti-Aging market is rising due to technological advancements in the genomics and biotechnology industry. The drive of the...
Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics
December 12, 2024 07:30 ET
|
Conduit Pharmaceuticals
Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics Approach
Avextra Supports First Fully EU-Funded Psilocybin Therapy Study, Now Approved by EMA
December 12, 2024 07:00 ET
|
Avextra Pharma GmbH
Exclusive Industry Role: Avextra is the industry partner in the first EU-funded project focused on psychedelic-assisted therapy for patients in palliative care suffering from depression, with a total...